1 Small-Cap Stock on Our Watchlist and 2 to Avoid
A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack
Myriad Genetics (MYGN): Buy, Sell, or Hold Post Q4 Earnings?
Why Are Myriad Genetics (MYGN) Shares Soaring Today
The S&P 500 Index ($SPX ) (SPY ) today is up +0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.43%. March E-mini S&P futures (ESH25...
Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks
Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4
Why Myriad Genetics (MYGN) Shares Are Plunging Today
Sarepta Therapeutics (SRPT) To Report Earnings Tomorrow: Here Is What To Expect